Cyclopamine: Strategic Insights for Translational Cancer Res
2026-04-27
This thought-leadership article offers mechanistic clarity and actionable strategy for translational researchers leveraging Cyclopamine as a Hedgehog signaling inhibitor. Drawing on recent advances in pathway biology, comparative analytics, and evidence-based product intelligence, it provides a blueprint for integrating Cyclopamine into cancer and developmental biology workflows, while bridging current gaps in experimental design and translational impact.
O-Propargyl-Puromycin: Redefining Protein Synthesis Detectio
2026-04-26
Explore how O-propargyl-puromycin (OPP) enables precise, real-time measurement of protein synthesis in the context of posttranscriptional regulation and mitochondrial integrity in B cells. Bridging cutting-edge mechanistic insights with translational research strategies, this article offers guidance on leveraging OPP for next-generation immunology, proteomics, and adaptive immunity studies.
Chloroquine for Research: Protocols, Applications, and Troub
2026-04-25
Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) stands at the intersection of anti-inflammatory, antimalarial, and antiviral research, offering robust pathway modulation through autophagy and Toll-like receptor inhibition. Uncover optimized workflows, troubleshooting strategies, and evidence-based guidance for maximizing Chloroquine’s experimental impact.
circ_0042103/TAF15/NER Axis Drives DNA Damage in Pulpitis
2026-04-24
This study uncovers how circ_0042103 interacts with TAF15 to downregulate NER pathway proteins, amplifying DNA damage and inflammation in dental pulp stem cells during pulpitis. The findings clarify a novel regulatory mechanism and highlight the importance of circular RNA enrichment tools for mechanistic studies in inflammatory dental disease.
Fosinopril Sodium: Precision ACE Inhibition for Hypertension
2026-04-24
Fosinopril sodium empowers cardiovascular and hypertension research with its phosphinic acid-based, third-generation ACE inhibition. This guide details optimized workflows, data-driven troubleshooting, and translational advantages for robust blood pressure and renal hemodynamics studies.
MiR-3180 Suppresses Hepatocellular Carcinoma via Lipid Metab
2026-04-23
Hong et al. (2023) identify miR-3180 as a critical suppressor of hepatocellular carcinoma (HCC) growth and metastasis, acting through coordinated inhibition of both fatty acid synthesis (via SCD1) and uptake (via CD36). This dual regulatory mechanism offers a promising target for therapeutic intervention and prognostic assessment in HCC.
Lipid Transfection’s New Frontier: Mechanistic Insight for T
2026-04-23
This thought-leadership article explores the mechanistic advances and strategic guidance for translational researchers navigating high-efficiency nucleic acid delivery. Focusing on the Lipo3K Transfection Reagent, we connect recent discoveries in multidrug resistance and membrane biology to actionable transfection strategies, highlighting opportunities for breakthrough gene expression and RNA interference studies in even the most challenging cellular models.
Mubritinib Disrupts OXPHOS to Inhibit KSHV-Driven PEL Cells
2026-04-22
This study identifies Mubritinib (TAK 165) as a selective mitochondrial complex I inhibitor that disrupts oxidative phosphorylation, leading to cell death in Kaposi’s sarcoma-associated herpesvirus (KSHV)-positive primary effusion lymphoma (PEL) cells. The work provides mechanistic evidence for repurposing Mubritinib in viral oncology, particularly where standard therapies fail.
6-Thioguanine Suppresses EV71 via BIRC3-Mediated Autophagy I
2026-04-22
This study demonstrates that 6-thioguanine (6-TG) potently inhibits Enterovirus 71 (EV71) replication in vitro by downregulating BIRC3-mediated autophagy. The findings provide new mechanistic insight into antiviral strategies for hand, foot, and mouth disease (HFMD), offering a promising direction for therapeutic development.
Berbamine Hydrochloride: Applied NF-κB Activity Inhibitor Wo
2026-04-21
Berbamine hydrochloride enables precision inhibition of NF-κB signaling, empowering researchers to dissect tumorigenic pathways and ferroptosis resistance in cancer models. This guide delivers validated assay protocols, troubleshooting strategies, and actionable insights for maximizing its impact in cancer research.
Transmission Dynamics of Carbapenemase Genes in CREC, Guangd
2026-04-21
This study systematically characterizes carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) isolates from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The findings reveal high multidrug resistance, predominant blaNDM-1 carriage, and efficient horizontal gene transfer, informing both resistance surveillance and experimental model design.
Programming CAR Macrophages In Situ Using mRNA-LNPs for Soli
2026-04-20
This study introduces a macrophage-targeted mRNA lipid nanoparticle system enabling in situ programming of chimeric antigen receptor (CAR) macrophages to enhance cancer immunotherapy, particularly against peritoneal metastases. By systematically evaluating diverse CAR designs, the research uncovers key regulatory mechanisms and demonstrates synergy with PD-1/L1 blockade, offering new insights into overcoming immunosuppressive tumor microenvironments.
Cefepime (BMY-28142): Applied Workflows in Resistance Modeli
2026-04-20
Cefepime (BMY-28142) empowers researchers to model central nervous system infections and unravel adaptive resistance mechanisms in Gram-positive and Gram-negative bacteria. This article translates advanced PKPD findings into actionable workflows, with real-world troubleshooting and comparative insights for high-sensitivity, reproducible research.
Angiotensin 1/2 (2-7): Benchmarks for Vasoconstrictor Peptid
2026-04-19
Angiotensin 1/2 (2-7) is a well-defined peptide fragment used in blood pressure regulation research and mechanistic renin-angiotensin system studies. Its biochemical, physiological, and workflow properties are supported by recent peer-reviewed evidence and high-purity product benchmarks. This article details its biological rationale, action, and integration guidelines for reproducible scientific research.
PPM-18 for iNOS Inhibition: Workflow, Troubleshooting, and I
2026-04-18
Harness the specificity of PPM-18 for advanced inflammation and sepsis models with precise inhibition of inducible nitric oxide synthase. This guide delivers data-driven protocols, troubleshooting strategies, and actionable insights grounded in recent translational research.
508 records 24/34 page Previous Next First page 上5页 2122232425 下5页 Last page